PRO MEDICUS LIMITED — AGM Information 2010

Nov 22, 2010

Annual General Meeting November 23rd 2010

Australia’s Leading HealthCare IT Company

• Peter Kempen- Chairman

Board Members

==> picture [186 x 422] intentionally omitted <==

• Sam Hupert – CEO & Deputy Chairman

• Anthony Hall – Executive Director

• Peter Jonson – Non-Executive Director

==> picture [776 x 27] intentionally omitted <==

Officers

==> picture [186 x 422] intentionally omitted <==

• Clayton Hatch – Finance Manager/Company Secretary

• Stuart Painter – Ernst and Young Auditor

In absentia:

• Danny Tauber – Chief Operating Officer

• Malte Westerhoff – Managing Director (Visage - Germany)

• John Danahy – National Business Manager (Visage - USA)

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – In Perspective

==> picture [182 x 422] intentionally omitted <==

• 2007/08 –Sustained profit growth and optimism re acquisition opportunity.

• 2008/09 – A time of change facing the global financial crisis, and changes with overseas partner (Agfa) . Visage acquisition.

• 2009/10 – A time of transition to a challenging but potentially much stronger future. Company re engineered.

==> picture [776 x 27] intentionally omitted <==

Board Changes

==> picture [186 x 422] intentionally omitted <==

• Mel Ward AO

• • David Chambers

• • Peter Jonson

• New Director • Rod Lyle

==> picture [776 x 27] intentionally omitted <==

• Sam Hupert- CEO

Pro Medicus – Key milestones

==> picture [192 x 401] intentionally omitted <==

• Release of the Visage 7.0 platform

• Right sizing of US operations

• Significant progress with new RIS technology platform

• Continued growth of Amira

• 3 Key sales of Visage 7.0 in Australia

• Increased brand awareness in US & Europe.

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – Integration

==> picture [211 x 287] intentionally omitted <==

• Alignment of R&D teams in Melbourne and Berlin

• New management structure

• Unified accounting and support systems

• Flexibility to use resources across three continents

==> picture [50 x 63] intentionally omitted <==

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – Visage 7.0

==> picture [188 x 401] intentionally omitted <==

Previously

• A niche market 3-D product

• Addressed 5% to 10% of market

Now

• Unique 2-D/3-D thin client platform - Universal viewer

• New generation 3-D PACS

• Addresses up to 85% of market

• Seen as technological leader

• Strong competitive advantage

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – US Operations

==> picture [186 x 422] intentionally omitted <==

• New general manager – 17 years industry experience

• New offices based in San Diego

• Right sizing of staff numbers

• More experienced sales staff

• Greater use of electronic marketing

• Decreased operating costs by $1M per annum

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – “Coral”

==> picture [198 x 214] intentionally omitted <==

• Entirely new technology platform

• • 3 Years in development

• • Release in December/January time frame

• • Repositions company as clear technology leader

• • Reduced cost of ongoing development

• • More cost effective to support

==> picture [198 x 213] intentionally omitted <==

==> picture [776 x 27] intentionally omitted <==

“Coral” – everything is new !

==> picture [651 x 397] intentionally omitted <==

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – Amira

==> picture [138 x 142] intentionally omitted <==

==> picture [176 x 150] intentionally omitted <==

==> picture [134 x 127] intentionally omitted <==

• 3D Toolkit for Life Sciences

• Sold through Web Store

• • Sales still growing strongly - 15% plus pa

• • Increases awareness of Visage brand

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – Key Sales

==> picture [192 x 401] intentionally omitted <==

• 3 major sales of Visage 7.0 in Australia

• Both new and existing clients

• • Helped develop new competencies

• • Forms base for future referral

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – Marketing

==> picture [191 x 420] intentionally omitted <==

• Electronic marketing successful

• • Leverages technology advantage

• • Validated by recent Frost and Sullivan award

• • Increased lead generation

==> picture [406 x 58] intentionally omitted <==

==> picture [776 x 27] intentionally omitted <==

RSNA Ad Campaign – Visage 7

==> picture [342 x 423] intentionally omitted <==

==> picture [79 x 79] intentionally omitted <==

==> picture [214 x 30] intentionally omitted <==

Healthcare Innovation of the Year Award

Now Apple MAC Compatible

==> picture [776 x 27] intentionally omitted <==

Pro Medicus, now truly global…

A Full Suite of Enterprise PACS/RIS/Visualization and E:Health Business Software Solutions

• Visage 7.0 - 3D PACS & Universal Viewer

• New Technology RIS Platform – “Coral”

• 70 employees, in three centers (US, Germany and Australia)

• ISO 9001 + 13485 certified, FDA/CE/CAMCAS cleared medical products

==> picture [514 x 229] intentionally omitted <==

----- Start of picture text -----

Berlin
Germany
San Diego, CA
USA
Melbourne
Australia
----- End of picture text -----

==> picture [776 x 27] intentionally omitted <==

2010/11 1[st] half to date

==> picture [194 x 422] intentionally omitted <==

• Consolidation period for new technology

• Australian market affected by government changes

• “Headwind” from adverse currency impact.

• • Increase in US and European opportunities

• • Momentum expected to build into the 2[nd] half

==> picture [776 x 27] intentionally omitted <==

Opportunities

==> picture [249 x 423] intentionally omitted <==

• Greater penetration of US markets

• Up-selling opportunities for Australian business

• Public hospitals both here and overseas

• New dealer channels and “pay per view” revenue streams.

• Push into Europe – particularly UK

==> picture [776 x 27] intentionally omitted <==

2010/11 Financial Outlook

==> picture [194 x 422] intentionally omitted <==

• Increased benefits to flow from Visage acquisition

• Technology value proposition to drive higher margins

• Continued investment in product development.

• Increased percentage of revenue from offshore

• Currency impact may remain an issue

• 2[nd] half to be stronger than 1st

==> picture [776 x 27] intentionally omitted <==

Growth strategies for 2010/2011

==> picture [734 x 322] intentionally omitted <==

----- Start of picture text -----

New sales
US and European
channels
expansion
Expanded Visage Imaging –
Promedicus
product portfolio continuing integration
New (RIS) Penetrate
technology platform hospital market
----- End of picture text -----

==> picture [776 x 27] intentionally omitted <==

==> picture [780 x 540] intentionally omitted <==

----- Start of picture text -----

•
Investments in R&D bearing fruit with milestones met
for new technology platform.
•
Ongoing investment in new people and infrastructure.
Underpins future by transitioning products to new
technology platform.
•
Increasing our presence and skills in North America.
•
.
Established a base in Europe
•
We now have the foundations for future growth in
local and overseas markets.
----- End of picture text -----

• My thanks to Directors for their strong contribution

• Thanks to our management and staff for their innovative creativity and hard work.

RESOLUTION OF SHAREHOLDERS

• Resolution 2 – To adopt the Remuneration Report (non binding)

FOR 67,746,792 82.61%

OPEN AGAINST 194,035 14,070,197 0.24% 17.15%

==> picture [776 x 27] intentionally omitted <==

RESOLUTION OF SHAREHOLDERS

• Resolution 3B – To elect as a Director Anthony Hall

FOR OPEN 51,713,584 204,035 99.51% 0.39%

AGAINST 51,752 0.10%

==> picture [776 x 27] intentionally omitted <==